Filter results by

Search Help
Currently selected filters that can be removed

Keyword(s)

Content

1 facets displayed. 0 facets selected.
Sort Help
entries

Results

All (111)

All (111) (50 to 60 of 111 results)

  • Articles and reports: 88F0006X2001011
    Description:

    This paper provides a summary of the strategies and business practices of biotechnology firms, and information on the business environment faced by these firms. These issues, considered in conjunction with information on revenue, research and development, import and export, product pipeline and human resources characteristics of biotechnology firms, contribute to a more comprehensive portrait of the biotechnology sector in Canada.

    Release date: 2001-08-28

  • Articles and reports: 88F0006X2001007
    Description:

    This paper provides estimates for firms actively involved in the development of new products and processes using biotechnologies. The survey examines the use of biotechnology and the development of biotechnologies in Canada's industrial sector for the 1999 fiscal year. The Biotechnology Use and Development Survey - 1999 was conducted as part of a project to develop biotechnology statistics and was funded under the Canadian Biotechnology Strategy. Several departments and agencies provided important inputs at various stages of the survey. They are Industry Canada, the Canadian Biotechnology Secretariat, Agriculture Canada, the National Research Council, the Canadian Institutes for Health Research, Natural Resources Canada, Department of Foreign Affairs and International Trade, Health Canada, and Environment Canada.

    Release date: 2001-03-30

  • Articles and reports: 88F0017M2001009
    Geography: Canada
    Description:

    This paper examines the call for an international effort to co-ordinate the measuring of biotechnology so that the ensuing statistics and indicators maintain some level of international comparability.

    Release date: 2001-02-15

  • Articles and reports: 88F0017M2000008
    Geography: Canada
    Description:

    This report examines the factors contributing to the rapid growth of a small number of biotechnology firms in Canada.

    Release date: 2000-08-28

  • Articles and reports: 88F0017M1999006
    Geography: Canada
    Description:

    This report describes the basic characteristics of the firms using biotechnologies, the type of use of biotechnologies, the stage of use and future use, the obstacles to acquisition and implementation of biotechnologies, the advantages obtained, and internal and external sources of information leading to biotechnology use.

    Release date: 1999-11-19

  • Articles and reports: 88F0006X1998005
    Description:

    Statistics Canada is engaged in the "Information System for Science and Technology Project" to develop useful indicators of activity and a framework to tie them together into a coherent picture of science and technology (S&T) in Canada. The working papers series is used to publish results of the different initiatives conducted within this project. The data are related to the activities, linkages and outcomes of S&T. Several key areas are covered such as: innovation, technology diffusion, human resources in S&T and interrelations between different actors involved in S&T. This series also presents data tabulations taken from regular surveys on research and development (R&D) and S&T and made possible by the project.

    Release date: 1998-10-30

  • Stats in brief: 11-001-X2016356942
    Description: Release published in The Daily – Statistics Canada’s official release bulletin
    Release date: 2016-12-21

  • Articles and reports: 88-003-X200800110579
    Geography: Canada
    Description:

    The last decade of the Innovation Analysis Bulletin (IAB) tells the story of the evolution of the Science, Innovation and Electronic Information Division (SIEID) and its precursor, the Science and Technology Redesign Project. This evolution brings all the measurement and analysis activities together in an integrated approach to understanding technological and related organizational change. This includes measurement of research and development resources allocated to the formal generation of knowledge (research and development); the use and commercialization of intellectual property of universities, government laboratories and businesses; the activity of innovation; and the adoption and use of advanced manufacturing technologies, biotechnologies, information communication technologies (ICTs), knowledge management practices, nanotechnologies, and emerging technologies.

    Release date: 2008-05-22

  • Articles and reports: 88-003-X200800110580
    Geography: Canada
    Description:

    Data collected through Statistics Canada's life sciences statistics program indicate that Canada has a sizable biotechnology sector in comparison with larger countries in Europe. This program regularly provides assistance to other countries, which view Canada as a world leader in the development of biotechnology statistics. This article notes the future directions and challenges facing the program.

    Release date: 2008-05-22

  • Articles and reports: 88-003-X200700210323
    Geography: Canada
    Description:

    Although nanotechnology can be thought of as a sector of its own, it is clear that nanotechnology is a cross-sector phenomenon with potentially significant impacts. Nanotechnologies can be found in areas as diverse as biotechnology and health, agriculture, electronics and computer technology, environment and energy, optics, and in materials and manufacturing.

    Release date: 2007-10-09
Stats in brief (8)

Stats in brief (8) ((8 results))

  • Stats in brief: 88-001-X201000211095
    Geography: Canada
    Description:

    Data for fiscal year 2008/2009 comprise science and technology (S&T) expenditures and full-time equivalent personnel allocated to biotechnology research and development (R&D) and related scientific activities (RSA) in selected federal government departments and agencies.

    Release date: 2010-03-10

  • Stats in brief: 88-001-X200900110802
    Geography: Canada
    Description:

    Data on science and technology (S&T) expenditures and full-time equivalent personnel allocated to biotechnology for fiscal year 2007/2008 were collected from selected federal government departments and agencies. The biotechnology S&T data comprise expenditures on research and development (R&D) and related scientific activities (RSA) for both intramural and extramural performers and the full-time equivalent personnel associated with these activities.

    Release date: 2009-03-04

  • Stats in brief: 88-001-X200800210604
    Description:

    Data on science and technology (S&T) expenditures and full-time equivalent personnel allocated to biotechnology for fiscal year 2006/2007 were collected from selected federal government departments and agencies.The biotechnology S&T data comprise expenditures on research and development (R&D) and related scientific activities (RSA) for both intramural and extramural performers and the full-time equivalent personnel associated with these activities.

    Release date: 2008-06-02

  • Stats in brief: 88-001-X20070039614
    Description:

    Data on science and technology (S&T) expenditures and full-time equivalent personnel allocated to biotechnology for fiscal year 2005/2006 were collected from selected federal government departments and agencies. This information contributes to the work of the Canadian Biotechnology Strategy. The biotechnology S&T data comprise expenditures on research and development (R&D) and related scientific activities (RSA) for both intramural and extramural performers and the full-time equivalent personnel associated with these activities.

    Release date: 2007-05-11

  • Stats in brief: 88-001-X20060029114
    Description:

    Data on science and technology (S&T) expenditures and full-time equivalent allocated to biotechnology for the fiscal year 2004/2005 were collected from selected federal departments and agencies. Survey results contribute to the work of the Canadian Biotechnology Strategy. The S&T data collected for biotechnology are composed of expenditures on research and development (R&D) and related scientific activities (RSA) for both intramural and extramural performers and also the full-time equivalent associated with these activities.

    Release date: 2006-03-09

  • Stats in brief: 88-001-X20050037933
    Description:

    Data on science and technology (S&T) expenditures and full-time equivalent allocated to biotechnology for the fiscal year 2003-2004 were collected from selected federal departments and agencies. Survey results contribute to the work of the Canadian Biotechnology Strategy.

    The S&T data collected for biotechnology are composed of expenditures on research and development (R&D) and related scientific activities (RSA) for both intramural and extramural performers and also the full-time equivalent associated with these activities.

    Release date: 2005-05-11

  • Stats in brief: 11-001-X2016356942
    Description: Release published in The Daily – Statistics Canada’s official release bulletin
    Release date: 2016-12-21

  • Stats in brief: 88-001-X20020037899
    Description:

    Data on science and technology (S&T) expenditures and person-years allocated to biotechnology for the year 2000-2001 were collected from selected federal departments and agencies. The criterion for selection was significant activity in this field. Survey results contribute to the work of the Canadian Biotechnology Strategy.

    Release date: 2002-05-01
Articles and reports (102)

Articles and reports (102) (0 to 10 of 102 results)

  • Articles and reports: 22-20-00012024002
    Description: This article explores trends in patent applications made by Canadian-resident businesses for advanced technologies from 2001 to 2019, drawing on Eurostat's aggregation of high-tech patents. Approximately one-third of applications fall under high-tech categories, the bulk of which were associated with Communication, Computer, and Automated business equipment technologies. While these fields saw growth until 2012, a subsequent decline occurred, notably in Computer and Electronic Product Manufacturing. Biotechnology, Semiconductors, and Lasers showed limited dynamism, while aviation technology applications surged by nearly twentyfold over the period.
    Release date: 2024-05-21

  • Articles and reports: 88-003-X200800110581
    Geography: Canada
    Description:

    When an existing firm decides not to commercially develop a discovery, enterprising entrepreneurs may establish a spinoff organization to pursue the venture. Of the 532 biotechnology firms in Canada in 2005, 179 reported that they were spinoffs from another organization.

    Release date: 2008-05-22

  • Articles and reports: 88-003-X200700210326
    Geography: Canada
    Description:

    Although private investors and government funding agencies have learned that the biotechnology sector requires a funding model different from that of traditional manufacturing, there is a paucity of empirical research investigating the links between characteristics of the funding model and firm performance. The purpose of this article is to examine which funding sources have the greatest influence on firm growth.

    Release date: 2007-10-09

  • Articles and reports: 88-003-X20070019620
    Geography: Canada, Province or territory
    Description:

    Preliminary data from the Biotechnology Use and Development Survey (BUDS) 2005 indicate that growth continued in the sector, but at a slower pace than has been reported in earlier years. This article highlights some key biotechnology indicators for innovative biotech firms in Canada, by sector, size and province.

    Release date: 2007-05-10

  • Articles and reports: 88-003-X20050038769
    Geography: Canada
    Description:

    In Canada, innovative biotechnology firms invest large amounts to develop new biotechnology products and processes. In 2003, they invested nearly $1.5 billion in research and development (R&D). In biotechnology, the development process is long and costly, with no guarantee of success. Some firms that discover a new biotechnology product or process with potential industrial applications may want to protect it against any infringement. The patent is a tool preferred by innovative biotechnology firms to protect their invention. This short article describes the patenting activities of biotechnology firms in 2003 and examines the relationship between patents and funding.

    Release date: 2005-10-26

  • Articles and reports: 88-003-X20050028021
    Geography: Canada
    Description:

    Between 1997 and 2003, the number of innovative biotechnology firms rose from 282 to 490. Biotechnology in Canada continued to expand between 2001 and 2003, generating revenues of almost $4 billion. Biotechnology companies have more than quadrupled their revenues since 1997, making biotechnology a fast growing activity.

    Release date: 2005-06-20

  • Articles and reports: 88-003-X20050017771
    Geography: Canada
    Description:

    Preliminary data indicate the biotechnology sector continued its phenomenal growth in Canada between 2001 and 2003, generating almost $4 billion in revenues. Biotechnology companies have more than quadrupled their revenues since 1997, making biotech a quickly growing activity.

    Release date: 2005-02-09

  • Articles and reports: 88-003-X20040037432
    Geography: Canada
    Description:

    This article is based on a recent series of interviews with leaders of high growth biotechnology firms. It highlights the importance of financing, management strategies and qualified personnel for achieving high growth.

    Release date: 2004-10-29

  • Articles and reports: 88-001-X20040077864
    Description:

    Data on science and technology (S&T) expenditures and person-years allocated to biotechnology for the year 2002-2003 were collected from selected federal departments and agencies. The criterion for selection was significant activity in this field. Survey results contribute to the work of the Canadian Biotechnology Strategy. The data collected for biotechnology are composed of research and development (R&D) and related scientific activities (RSA) expenditures, for intramural and extramural activities, by performer, and also the person-years associated with these activities.

    Release date: 2004-07-19

  • Articles and reports: 88-003-X20040026930
    Geography: Canada
    Description:

    Biotechnology activity in Canada is flourishing. The total number of biotechnology firms has been continually increasing in recent years. This expansion can also be observed from the changes in revenues generated by biotechnology. Research and development (R&D) efforts are starting to bear fruit and this is reflected in the revenue ratio on R&D.

    Release date: 2004-06-30
Journals and periodicals (1)

Journals and periodicals (1) ((1 result))

  • Journals and periodicals: 88-003-X
    Geography: Canada
    Description:

    The bulletin summarizes and highlights new results in the analysis of science, technology and the information society. The articles cover current issues in science and technology activities, advanced technologies, innovation in industry and electronic media. The bulletin is designed to be easily readable by non-experts.

    Release date: 2009-06-05
Date modified: